First up is the ADEPT study in bullous pemphigoid (BP), a rare skin condition that leads to reddening of the skin and the formation of painful and intensely itchy chronic lesions and blisters ...

Envestnet Portfolio Solutions Inc. increased its stake in shares of argenx SE (NASDAQ:ARGX – Free Report) by 7.9% in the 4th quarter, Holdings Channel reports. The firm owned 1,509 shares of the ...

The oral mucosa represents a fascinating scenario in the setting of medical research for its peculiar immune mileu. Not only the oral cavity hosts specific immune cells interacting with the local ...

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

After hours: 18 March at 7:16:59 pm GMT-4 Loading Chart for SNY ...